Eve Kennedy, PhD

Eve joined the company in 2020, taking on leadership of key areas of the business including Research and Development, and Manufacturing. Eve holds a PhD from the University of Adelaide and received a Dean’s Commendation for Research Thesis Excellence. She brings expertise in immunology and vaccinology, having contributed to several research projects developing viral vaccines including vaccines for influenza A virus, rotavirus, Zika virus and Newcastle disease virus. In addition to her research and leadership contributions, Eve is a co-inventor on several patents.